Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma

NCT00338988 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Gallbladder
Cancer of the Biliary Tract

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]